I
schemic preconditioning (IPC) is the endogenous mechanism whereby brief periods of ischemia paradoxically protect the myocardium against the damaging effects of subsequent prolonged ischemia. 1 IPC exists in all species examined, including humans. [2] [3] [4] Although the precise cellular mechanisms responsible for IPC remain elusive, adenosine released by the ischemic heart has been reported to initiate IPC. 5 Protein kinase C (PKC) features prominently in the signal transduction pathway between adenosine A 1 receptors and the final effector. 6 Adenosine and PKC have been shown to activate ATP-sensitive potassium (K ATP ) channels in cardiac myocytes. [7] [8] [9] Consistent with the idea that K ATP channels may be the end effectors of IPC, stimulation of adenosine A 1 receptors mimics IPC, and this effect is abolished by the K ATP channel inhibitor glibenclamide. 10 The cardioprotective effects were initially attributed to sarcolemmal K ATP (surfaceK ATP ) channels. 11, 12 However, recent studies provide evidence that mitochondrial K ATP (mitoK ATP ) channels are the dominant players. Diazoxide, a selective mitoK ATP channel opener in cardiac cells, 13 protects rabbit ventricular myocytes in a pelleting model of ischemia, 14 improves functional recovery after ischemia in Langendorff-perfused rat and rabbit hearts, 15 and reduces infarct size in rabbit hearts. 16 On the other hand, the selective mitoK ATP channel blocker 5-hydroxydecanoate (5HD) 17 antagonizes diazoxide-induced cardioprotection 14, 15 and abolishes genuine IPC. 18 -20 Furthermore, PKC activation potentiates mitoK ATP channel opening in rabbit ventricular myocytes. 17 Accordingly, the present study was designed to determine whether adenosine modulates mitoK ATP channels. Our results demonstrate that adenosine potentiates mitoK ATP channel activation via a PKC-mediated pathway and protects the myocardium from ischemia.
Methods
The investigation conforms with the Guide for the Care 
Preparation of Rabbit Myocytes
Rabbit ventricular myocytes were isolated by conventional enzymatic dissociation, as described previously. 9 In brief, hearts were excised from anesthetized (30 mg/kg pentobarbital IV) New Zealand White rabbits (weighing 1 to 2 kg) and mounted on a Langendorff apparatus. The heart was perfused with modified Krebs-Henseleit solution composed of (mmol/L) NaCl 119, KCl 5, NaHCO 3 25 , KH 2 PO 4 1, MgSO 4 1, CaCl 2 2, and glucose 10. The perfusate was bubbled with 95% O 2 /5% CO 2 and maintained at 37°C. After 5 minutes of perfusion, hearts were perfused without Ca 2ϩ for another 5 minutes, after which the perfusion solution was switched to one containing collagenase (0.8 mg/mL, Worthington type II). The perfusion pressure was monitored, and the flow rate was adjusted to maintain perfusion pressure at Ϸ75 mm Hg. After 25 to 30 minutes of collagenase perfusion, hearts were removed from the perfusion apparatus, and the atria were trimmed away. The ventricles were minced and incubated in a shaking bath for another 5 minutes in collagenase-containing solution. Cells were then filtered through nylon mesh and washed several times with Ca 2ϩ -free solution. Calcium concentration was gradually brought back to 1 mmol/L.
Flavoprotein Fluorescence
Opening of mitoK ATP channels dissipates the inner mitochondrial membrane potential established by the proton pump. This dissipation accelerates electron transfer by the respiratory chain and, if uncompensated by increased production of electron donors, leads to net oxidation of the mitochondria. Therefore, the mitochondrial redox state was monitored by measuring the autofluorescence of flavin adenine dinucleotide-linked enzymes in the mitochondria, as described by Liu et al. 14 After isolation, cells were cultured on laminin-coated coverslips in medium 199 with 5% FBS at 37°C. Experiments were performed the next day. Cells were placed in a recording chamber and superperfused with external solution containing (mmol/L) NaCl 140, KCl 5, MgCl 2 1, CaCl 2 1, and HEPES 10 (pH 7.4 with NaOH) at room temperature (Ϸ22°C). Endogenous flavoprotein fluorescence was excited for 100 ms every 6 seconds by use of a xenon arc lamp with a band-pass filter centered at 480 nm. Emitted fluorescence was recorded at 530 nm by a photomultiplier tube and digitized. The redox signal was averaged during the excitation window and calibrated with the values after exposure to 2,4-dinitrophenol (DNP), which uncouples respiration from ATP synthesis, collapses the mitochondrial potential, and induces maximal oxidation. Therefore, the values of flavoprotein fluorescence were expressed as a percentage of the DNP-induced fluorescence. By focusing on individual myocytes with a ϫ40 objective, fluorescence was monitored from one cell at a time.
Cellular Model of Simulated Ischemia
A cellular model of simulated ischemia modified from Vander Heide et al 21 was used to quantify cell injury. In brief, cells were washed with incubation buffer containing (mmol/L) NaCl 119, NaHCO 3 25 , KH 2 PO 4 1.2, KCl 4.8, MgSO 4 1.2, CaCl 2 1, HEPES 10, glucose 11, creatine 24.9, and taurine 58.5 and supplemented with 1% basal medium eagle amino acids and 1% minimum essential medium nonessential amino acids (pH 7.4 with NaOH). An aliquot of each cell suspension (0.5 mL) was placed into a microcentrifuge tube and centrifuged for 15 seconds into a pellet. Approximately 0.25 mL of excess supernatant was removed to leave a thin fluid layer above the pellet, and 0.2 mL of mineral oil was layered on the top of the pellet to prevent gaseous diffusion. After 60 and 120 minutes of simulated ischemia, 5 L of cell pellet was sampled through the oil layer and mixed with 75 L of 85 mOsm/L hypotonic staining solution containing (mmol/L) NaHCO 3 11.9, KH 2 PO 4 0.4, KCl 2.7, MgSO 4 0.8, and CaCl 2 1, along with 0.5% glutaraldehyde and 0.5% trypan blue. Microscopic examination was performed 2 to 5 minutes after mixing to determine the permeability of the cells to trypan blue. Cells permeable to trypan blue were counted as stained (ie, irreversibly injured) and expressed as a percentage of the total cells counted (Ͼ300 for each sample). In the control group, cells were pelleted and sampled at 60 and 120 minutes. For the adenosine-treated group, adenosine at a concentration of 100 mol/L was added to the solution 15 minutes before the pelleting. Cells treated with adenosine in the presence of 500 mol/L 5HD or in the presence of 30 mol/L HMR1098 were likewise pelleted and sampled. In another series of experiments, cells exposed to various concentrations of diazoxide with or without 100 mol/L adenosine were pelleted and sampled after 60 minutes of simulated ischemia. Once applied, drugs were not washed out and thus were present throughout the period of simulated ischemia. Experiments were performed at 37°C. Individual experiments in each group were performed on cells isolated from different hearts.
Chemicals
Collagenase (type II) was purchased from Worthington. Adenosine, diazoxide, 8-(p-sulfophenyl)-theophylline (SPT), polymyxin B, and DNP were obtained from Sigma Chemical Co. Sodium 5HD was purchased from Research Biochemicals International. HMR1098 was a gift from Hoechst Marion Roussel Chemical Research (Frankfurt, Germany). Adenosine, diazoxide, and SPT were dissolved in dimethyl sulfoxide before being added into experimental solutions. The final concentration of dimethyl sulfoxide was Ͻ0.1%.
Quantitative Modeling of Channel Function
To rationalize the opening of mitoK ATP channels underlying flavoprotein oxidation, we implemented Markov gating models of the Hodgkin-Huxley type ( Figure 7B ). 22 As a first approximation, we assumed that flavoprotein oxidation parallels mitoK ATP channel opening. Simulations were executed by use of Origin (Microcal Software) on a personal computer ( Figure 7C and 7D ).
Data Analysis
Data are presented as meanϮSEM, and the number of cells or experiments is shown as n. Cell pelleting data were analyzed by ANOVA combined with the Fisher post hoc test, and fluorescence data were analyzed by the Student t test. 23, 24 A value of PϽ0.05 was considered significant.
Results
The effects of adenosine on mitoK ATP channels were examined by measuring flavoprotein oxidation elicited by diazoxide. Figure 1A shows representative recordings of flavoprotein fluorescence in a cell exposed twice to diazoxide. Diazoxide (100 mol/L) reversibly oxidized flavoproteins via the opening of mitoK ATP channels. 14 Subsequent exposure to adenosine (100 mol/L) alone had no effects on flavoprotein fluorescence, but a second application of diazoxide in the continued presence of adenosine increased flavoprotein fluorescence above the levels reached in the first application. Note also that in the presence of adenosine, the second application of diazoxide elicited oxidation more quickly than the first. As summarized in Figure 1B , diazoxide (100 mol/L) reversibly increased flavoprotein oxidation to 42Ϯ5% of the DNP value (nϭ5). Adenosine (100 mol/L) significantly increased the diazoxide-induced flavoprotein oxidation to 57Ϯ4% of the DNP value (nϭ5, PϽ0.01). Figure 1C summarizes the latency to mitoK ATP activation, measured as the time required to increase flavoprotein oxidation to 20% of maximal after application of diazoxide. The exposures to diazoxide in the presence of adenosine abbreviated the latency from 6.6Ϯ1.1 to 4.3Ϯ0.5 minutes (nϭ5, PϽ0.05). Repeated applications of diazoxide alone neither potentiate nor accelerate flavoprotein oxidation. 17 To confirm that adenosine potentiated and accelerated the oxidative effect of diazoxide via stimulation of adenosine A 1 receptors, we examined the effects of the adenosine A 1 receptor antagonist SPT. When 100 mol/L SPT was present in the perfusate, adenosine (100 mol/L) failed to augment the oxidative effect of diazoxide and did not abbreviate the latency to mitoK ATP activation ( Figure 2A ). As summarized in Figure 2B , in the presence of SPT (100 mol/L) with adenosine (100 mol/L), diazoxide increased flavoprotein oxidation to 38Ϯ9% of the DNP value (nϭ4). This degree of oxidation was comparable to that achieved by exposure to diazoxide alone (41Ϯ6% of the DNP value, nϭ4). Furthermore, the latency to mitoK ATP activation was not abbreviated when the adenosine was co-applied with SPT (6.8Ϯ1.3 versus 6.5Ϯ1.4 minutes, nϭ4, PϭNS) ( Figure 2C ). We also examined whether activation of endogenous PKC by adenosine results in mitoK ATP channel activation. Chelerythrine and calphostin C, both of which are reported to be more selective PKC inhibitors, enhanced the emitted fluorescence signal nonspecifically. Therefore, polymyxin B was used to inhibit endogenous PKC in the present experiments. As shown in Figure 3 , in the presence of polymyxin B (50 mol/L), adenosine (100 mol/L) did not alter the oxidative effect of diazoxide (43Ϯ3% versus 42Ϯ2% of the DNP value, nϭ5, PϭNS) and could not abbreviate the latency to mitoK ATP activation (7.9Ϯ0.9 versus 8.4Ϯ0.7 minutes, nϭ5, PϭNS).
To verify that the diazoxide-induced flavoprotein oxidation observed in the presence of adenosine reflects the activation of mitoK ATP channels, the effects of the mitoK ATP channel blocker 5HD were examined. 5HD (500 mol/L) suppressed diazoxide-induced flavoprotein oxidation from 39Ϯ4% to 9Ϯ2% of the DNP value (nϭ4, PϽ0.01), even with the concomitant application of adenosine (Figure 4 ). These results indicate that adenosine primes the opening of mitoK ATP channels through the adenosine A 1 receptor-mediated activation of PKC.
Our finding that adenosine increases diazoxide-induced mitochondrial oxidation begs the question of whether adenosine potentiates diazoxide-induced cardioprotection. Figure  5 plots the fraction of cells stained by 60 minutes of simulated ischemia as a percentage of the total number of viable cells before ischemia. Diazoxide decreased the percentage of cells stained during 60 minutes of ischemia, in a concentrationdependent manner. Inclusion of 100 mol/L adenosine alone significantly decreased the extent of cell staining during ischemia. In addition, the cardioprotective effects of diazoxide were significantly augmented by simultaneous application of 100 mol/L adenosine. The cardioprotection in the presence of both diazoxide (100 mol/L) and adenosine (100 mol/L) surpassed the level achieved by diazoxide alone (11Ϯ1%, nϭ5).
In the next series of experiments, we tested the idea that mitoK ATP channels rather than surfaceK ATP channels act as effectors for cardioprotection afforded by adenosine. As shown in Figure 6 , simulated ischemia for 60 and 120 minutes stained 37Ϯ2% (nϭ6) and 47Ϯ2% (nϭ4) of cells, respectively (control group). Inclusion of adenosine (100 mol/L) significantly decreased the cells stained during ischemia to 21Ϯ2% (nϭ6) after 60 minutes and 27Ϯ3% (nϭ4) after 120 minutes of ischemia (adenosine-treated group, PϽ0.001 versus control group). The cardioprotective effects of adenosine were abolished by 500 mol/L 5HD (40Ϯ4% after 60 minutes and 49Ϯ3% after 120 minutes of ischemia). In contrast, the selective surfaceK ATP channel inhibitor HMR1098 (30 mol/L) did not abolish the cardioprotection by adenosine. These results indicate that adenosine primes the opening of mitoK ATP channels and thereby protects myocytes against ischemic damage.
Discussion
Diazoxide targets mitoK ATP but not surfaceK ATP channels in heart cells and oxidizes the mitochondrial matrix by opening mitoK ATP channels. 14 The oxidative effects of diazoxide are reversible and reproducible: under basal conditions, the degree of oxidation is identical during first and second exposures to diazoxide, and there is no significant difference in the latencies during first and second exposures. 14, 17 In the present study, we found that adenosine potentiated the oxidative effects of diazoxide and abbreviated the latency to mitoK ATP channel activation on the application of diazoxide (Figure 1) . The results agree qualitatively and quantitatively with those of Sato et al, 17 in which PKC-activating phorbol ester (phorbol 12-myristate 13-acetate) augmented and accelerated the mitochondrial oxidation induced by diazoxide. These findings led us to test the idea that PKC is downstream from the adenosine A 1 receptor and precedes the activation of mitoK ATP channels. Both the A 1 receptor antagonist SPT and the PKC inhibitor polymyxin B prevented the ability of adenosine to augment and accelerate the oxidative effect of diazoxide (Figures 2 and 3) . Moreover, the mitoK ATP channel inhibitor 5HD blocked diazoxide-induced mitochondrial matrix oxidation in the presence of adenosine (Figure 4) . These results taken together suggest that adenosine A 1 receptors link to mitoK ATP channels through PKC.
We have observed 2 classes of effects of agents on mitoK ATP channels. The K ATP channel openers diazoxide and pinacidil open the channels directly, leading to net mitochondrial oxidation. 14, 17 In contrast, adenosine and PKCstimulating phorbol esters act to prime the channels 17 : instead of opening them directly, these agents potentiate the subsequent opening of mitoK ATP channels. Thus, we propose the mechanism depicted schematically in Figure 7A . MitoK ATP channels exist in 3 distinct states: resting, primed, and open. "Virgin" myocardium contains only resting channels. Such channels cannot open directly; they must first traverse through several intermediate nonconducting states before opening. Diazoxide application to resting channels initiates the opening process, but a delay is introduced by the obligatory transit through intermediate nonconducting states. Adenosine and PKC activators shift mitoK ATP channels into the primed conformation, from which they can open in response to subsequent direct activation. Diazoxide readily opens channels that are primed; however, the response in virgin myocardium is slow, because the primed channel state is unpopulated. To test whether the scheme in Figure 7A suffices to reproduce our findings, we created an equivalent Markov model for quantitative simulation ( Figure 7B ). 22 We assume that virgin channels are all in the C 1 state; exposure to adenosine or PKC activators shifts the channels into the primed C* state. Exposure to diazoxide initiates channel opening, either along the upper (virgin) trajectory (C 1 7 C 2 7 C 3 7 C 4 7 O) or along the lower (preconditioned) one (C*7 O*). The simulation results in Figure 7C reveal that exposure of virgin myocardium to diazoxide opens the channels with some delay. In contrast, Figure 7D shows that diazoxide opens primed channels briskly and intensely. Note that adenosine itself does not open the channels; it merely shifts them into a primed state from which they can open much more readily. The sort of mechanism proposed in Figure 7 has close parallels in numerous studies of ion channels. The model itself is a direct adaptation of the classical Hodgkin-Huxley gating scheme for voltage-dependent potassium channels. 22 The proposed regulatory mechanism also has wellestablished precedents. For example, L-type calcium channels open in response to membrane depolarization, but they do so quite infrequently in the basal "resting" state. cAMPdependent phosphorylation shifts the channels into "primed" states, from which they open much more vigorously in response to depolarization, but such phosphorylation does not suffice to open the channels. 25, 26 Pharmacological agonists (eg, Bay K8644, Bayer) can open calcium channels directly in a manner quite analogous to the ability of diazoxide to open mitoK ATP channels. 25 Although the model rationalizes the pharmacology and regulation of mitoK ATP channels in a biologically plausible manner, we must stress that it is presented primarily for heuristic reasons; the details (eg, the precise number of nonconducting states) are underconstrained and subject to refinement as more data become available.
The model proposed in Figure 7 rationalizes the combined effects of adenosine and diazoxide: cardioprotection would be maximized if both priming and direct activation are operative. Similar reasoning may explain the cardioprotective effects of adenosine itself. Despite the fact that adenosine does not suffice to open mitoK ATP channels, it shifts channels into the primed state, from which they can be opened much more readily by endogenous stimuli during ischemia (most likely ATP depletion and/or ADP accumulation, 27 although changes in guanine nucleotides 28 or nitric oxide 29 may also play a role). Thus, adenosine can be cardioprotective without direct channel opening.
The salient novel finding from the present study is that the cardioprotection induced by adenosine can be inhibited by the mitoK ATP channel blocker 5HD but not by HMR1098 ( Figure  6 ). Unlike 5HD, HMR1098 30 targets surfaceK ATP without suppressing mitoK ATP channels: HMR1098 at the concentration used in the present study (30 mol/L) inhibits surface K ATP currents activated by metabolic inhibition and by surfaceK ATP channel opener P-1075 but has no effect on mitoK ATP channels in rabbit ventricular cells. 31 These results, taken together, indicate that cardioprotective effects of adenosine are mediated by the opening of mitoK ATP channels.
How might IPC be explained from the present results? We conjecture that in preconditioned myocardium, adenosine receptor activation primes mitoK ATP channels in a PKCdependent manner. Consequently, rapid and robust opening of mitoK ATP channels during lethal ischemia protects myocytes against ischemic damage. In agreement with this notion, Miura et al 32 have reported that the adenosine A 1 receptor agonist R-phenylisopropyl-adenosine mimics the infarct sizelimiting effects of IPC; this protection is prevented by the PKC inhibitor calphostin C and the mitoK ATP channel inhibitor 5HD. The findings further implicate mitoK ATP channels and provide tangible links among various key elements in the preconditioning cascade. 
